Brian W. Behm, MD
Graduate School: University of Virginia (MD, fellowship); UC San Francisco (residency)
Primary Appointment: Assistant Professor, Medicine, Gastroenterology and Hepatology
Research Interests: Translational and clinical research studying potential new therapies fro Crohn's disease and ulcerative colitis
Email Address: email@example.com
Dr. Behm's research interests include understanding the pathogenesis of intestinal inflammation, noninvasive imaging of the small and large intestine, and translational and clinical research studying potential new therapies for inflammatory bowel disease. He is currently studying the role of statins in decreasing intestinal inflammation in patients with Crohn's disease and is active in several clinical trials evaluating new therapies for ulcerative colitis and Crohn’s disease.
Behm BW, Bickston SJ. Humanized antibody to the alpha4beta7 integrin for the induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007571.
Behm BW, Bickston SJ. Tumor Necrosis Factor-Alpha Antibody for Maintenance of Remission in Crohn’s Disease. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006893.
Behm BW, Bickston SJ. Efficacy of infliximab for luminal and fistulizing Crohn’s disease and ulcerative colitis. Curr Treat Options Gastroenterol. 2007;10:171-7.
Behm BW, Bickston SJ. Medical management of Crohn’s disease: Current therapies and recent advances. Exp Rev Clin Immunol 2006;2:109-120.
|Office Address:||PO Box 800708, Charlottesville, VA 22908-0708